Plexus (NASDAQ:PLXS) Announces Q1 2027 Earnings Guidance

Posted by on Oct 30th, 2026

Plexus (NASDAQ:PLXS – Get Free Report) issued an update on its first quarter 2027 earnings guidance on Friday morning. The company provided earnings per share (EPS) guidance of 2.460-2.620 for the period, compared to the consensus estimate of 2.340. The company issued revenue guidance of $1.4 billion-$1.5 billion, compared to the consensus revenue estimate of $1.4 billion.

Analyst Upgrades and Downgrades

A number of research firms recently commented on PLXS. Zacks Research upgraded Plexus from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, August 11th. Needham & Company LLC reiterated a “buy” rating and issued a $310.00 target price on shares of Plexus in a report on Friday, August 14th. Wall Street Zen lowered shares of Plexus from a “buy” rating to a “hold” rating in a research report on Saturday, October 24th. Sidoti upgraded Plexus from a “neutral” rating to a “buy” rating and set a $308.00 price target on the stock in a report on Friday, July 31st. Finally, KeyCorp raised Plexus from a “sector weight” rating to an “overweight” rating and set a $300.00 price objective on the stock in a research report on Monday, September 21st. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Plexus presently has an average rating of “Buy” and an average price target of $276.86.

Check Out Our Latest Stock Report on PLXS

Plexus Stock Performance

Shares of NASDAQ:PLXS opened at $216.32 on Friday. The firm’s 50 day simple moving average is $247.43 and its 200-day simple moving average is $239.20. The firm has a market cap of $5.79 billion, a PE ratio of 29.15 and a beta of 0.88. Plexus has a one year low of $132.03 and a one year high of $307.06. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.72 and a current ratio of 1.49.

Plexus (NASDAQ:PLXS – Get Free Report) last issued its earnings results on Wednesday, October 28th. The technology company reported $2.84 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.55 by $0.29. The company had revenue of $1.43 billion for the quarter, compared to analysts’ expectations of $1.36 billion. Plexus had a net margin of 4.08% and a return on equity of 13.50%. The firm’s quarterly revenue was up 34.9% on a year-over-year basis. During the same period in the prior year, the business earned $2.14 EPS. As a group, equities analysts predict that Plexus will post 8.55 EPS for the current year.

Insider Activity

In other Plexus news, CEO Todd Kelsey sold 1,500 shares of the stock in a transaction dated Wednesday, October 21st. The stock was sold at an average price of $239.16, for a total value of $358,740.00. Following the completion of the sale, the chief executive officer directly owned 62,888 shares in the company, valued at approximately $15,040,294.08. This trade represents a 2.33% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Michael V. Schrock sold 4,000 shares of Plexus stock in a transaction that occurred on Tuesday, August 11th. The stock was sold at an average price of $275.00, for a total transaction of $1,100,000.00. Following the completion of the sale, the director owned 40,329 shares of the company’s stock, valued at $11,090,475. This trade represents a 9.02% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 9,000 shares of company stock worth $2,319,260. Insiders own 1.78% of the company’s stock.

Key Stories Impacting Plexus

Here are the key news stories impacting Plexus this week:

  • Positive Sentiment: Results exceeded expectations. Plexus reported fourth-quarter revenue of $1.427 billion, up 34.9% year over year, and non-GAAP diluted EPS of $2.84 versus analysts’ expectations near $2.55-$2.57. GAAP EPS was $2.51, while operating margin improved to 6.0%. Plexus Fiscal Fourth-Quarter Results
  • Positive Sentiment: Record growth and stronger profitability targets support the long-term outlook. Fiscal 2026 revenue reached $4.965 billion, up 23% year over year, and adjusted operating margin was 6.2%. Management raised its long-term non-GAAP operating-margin goal to 6.5%-7.0% and expects mid- to upper-teens revenue growth in fiscal 2027.
  • Positive Sentiment: Demand indicators remained robust. Plexus won 36 manufacturing programs representing $290 million in annualized revenue at full ramp, while its qualified opportunity funnel expanded 33% year over year to $4.9 billion. The company also authorized a new $100 million fiscal 2027 share-repurchase program. Plexus Earnings Guidance
  • Neutral Sentiment: First-quarter guidance points to continued revenue growth but normalizes earnings. Plexus forecast revenue of $1.410-$1.460 billion and adjusted EPS of $2.46-$2.62 for the quarter ending January 2, 2027. Revenue is expected to rise modestly from the fourth quarter, but the EPS range is below the $2.84 reported for Q4, likely reflecting seasonality and ongoing investment.
  • Negative Sentiment: Cash generation and concentration are investor concerns. Despite $6.4 million of fourth-quarter free cash flow, fiscal-year free cash flow was negative $28.9 million as inventory and receivables increased. The top 10 customers accounted for 56% of quarterly revenue, up from 49% a year earlier, increasing exposure to customer delays or program changes.

About Plexus

(Get Free Report)

Plexus Corp. is an electronics manufacturing services company that helps customers design, develop, manufacture and service complex electronic products. The company provides an integrated product-realization process spanning engineering and design, supply-chain management, manufacturing, testing, logistics and aftermarket services.

Plexus supports original equipment manufacturers in industries including healthcare and life sciences, industrial and commercial, aerospace and defense, and communications.

Read More

Earnings History and Estimates for Plexus (NASDAQ:PLXS)

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.